Bill & Melinda Gates Foundation (BMGF)
This sponsor has funded 2 studies across 7 countries.
| EU PAS ID | Status | RMP requirement | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|---|
| 34411 | Finalised | Not included in RMP | Real-world characteristics, management and outcomes of subjects screened or diagnosed with COVID-19 in Spain (COVID-19 REAL) | Yes | No |
| 37225 | Planned | Not included in RMP | Project Sc(y)lla: SARS-Cov-2 Large-scale Longitudinal Analyses on the comparative safety and effectiveness of treatments under evaluation for... | Yes | No |
PAS by Risk Management Plan (RMP) requirement
Bill & Melinda Gates Foundation (BMGF)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Bill & Melinda Gates Foundation (BMGF)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Bill & Melinda Gates Foundation (BMGF)
7 Study countries specified are the following:
- France
- Germany
- Korea, Republic of
- Netherlands
- Spain
- United Kingdom
- United States